Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases. (Q47720903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

title

Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

Ana Lúcia S Rodrigues

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

Ana B Ramos-Hryb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

Manuella P Kaster

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Francis L Pazini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

publication date

1 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

1029-1041

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

The global burden of neurologic diseases.

8 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Neurodegeneration, Neuroregeneration, and Neuroprotection in Psychiatric Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Oleanolic acid and ursolic acid: research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic Acid--A Pentacyclic Triterpenoid with a Wide Spectrum of Pharmacological Activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid (UA): A metabolite with promising therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Pharmacological activities of natural triterpenoids and their therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Fruit cuticular waxes as a source of biologically active triterpenoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Pentacyclic triterpene distribution in various plants - rich sources for a new group of multi-potent plant extracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Phytochemical constituents from the fruits of Acanthopanax sessiliflorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Spasmolytic and antinociceptive activities of ursolic acid and acacetin identified in Agastache mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid from Agastache mexicana aerial parts produces antinociceptive activity involving TRPV1 receptors, cGMP and a serotonergic synergism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Protective effects of the key compounds isolated from Corni fructus against β-amyloid-induced neurotoxicity in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

In vivo anti-nociceptive and anti-inflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, from Cussonia bancoensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Monoamine Oxidase and Dopamine β-Hydroxylase Inhibitors from the Fruits of Gardenia jasminoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Effects of acute administration of the hydroalcoholic extract of mate tea leaves (Ilex paraguariensis) in animal models of learning and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

CNS activity of the methanol extract of Mallotus peltatus (Geist) Muell Arg. leaf: an ethnomedicine of Onge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

A Rapid LC/MS/MS Method for the Analysis of Nonvolatile Antiinflammatory Agents from Mentha spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Anti-stress Activity of Ocimum sanctum: Possible Effects on Hypothalamic-Pituitary-Adrenal Axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Antidepressant-like effects of fractions, essential oil, carnosol and betulinic acid isolated from Rosmarinus officinalis L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Bioactive constituents of Salvia chrysophylla Stapf

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Isosakuranetin-5-O-rutinoside: a new flavanone with antidepressant activity isolated from Salvia elegans Vahl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Development of LC-MS method for determination of ursolic acid: application to the analysis of ursolic acid in Staphylea holocarpa Hemsl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Proliferation-inhibiting and apoptosis-inducing effects of ursolic acid and oleanolic acid on multi-drug resistance cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Antitumor Effects of Ursolic Acid in a Mouse Model of Postmenopausal Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Neuroprotection in Neurodegenerative Disease: From Basic Science to Clinical Applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Disease model: Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Cellular models for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Kainic Acid‐Induced Neurodegenerative Model: Potentials and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid protects hippocampal neurons against kainate-induced excitotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Recent Progress in Alzheimer's Disease Research, Part 1: Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

A high content drug screen identifies ursolic acid as an inhibitor of amyloid beta protein interactions with its receptor CD36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

p-Coumaric acid and ursolic acid from Corni fructus attenuated β-amyloid(25-35)-induced toxicity through regulation of the NF-κB signaling pathway in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

An overview of APP processing enzymes and products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

BACE1 inhibitor drugs in clinical trials for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Inhibitory Effects of Key Compounds Isolated from Corni fructus on BACE1 Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

The therapeutic potential of monoamine oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Substrate and drug binding sites in LeuT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IκB kinase β/nuclear factor-κB-mediated inflammatory pathways in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-κB mediated inflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Tests of unconditioned anxiety - pitfalls and disappointments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Assessing spatial learning and memory in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid promotes the neuroprotection by activating Nrf2 pathway after cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Behavioural study of the D-galactose induced aging model in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid attenuates D-galactose-induced inflammatory response in mouse prefrontal cortex through inhibiting AGEs/RAGE/NF-κB pathway activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic Acid Ameliorates Early Brain Injury After Experimental Traumatic Brain Injury in Mice by Activating the Nrf2 Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid improves domoic acid-induced cognitive deficits in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Tests to assess motor phenotype in mice: a user's guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

beta-Amyloid protein-induced Alzheimer's disease animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid attenuates beta-amyloid-induced memory impairment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Animal models of depression: molecular perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Triple reuptake inhibitors: the next generation of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

DOV 216,303, a "triple" reuptake inhibitor: safety, tolerability, and pharmacokinetic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid affords antidepressant-like effects in mice through the activation of PKA, PKC, CAMK-II and MEK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

What is the genetic relationship between anxiety and depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Anxiolytic-like effects of ursolic acid in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid enhances pentobarbital-induced sleeping behaviors via GABAergic neurotransmission in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Sleep disturbance in mental health problems and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic Acid-induced elevation of serum irisin augments muscle strength during resistance training in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40263-017-0474-4

Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase

21 January 2018

1 reference

12 December 2020

The role of stress in neurodegenerative diseases and mental disorders.

1 reference

12 December 2020

Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model

1 reference

12 December 2020

Antidepressant-like effect of ursolic acid isolated from Rosmarinus officinalis L. in mice: Evidence for the involvement of the dopaminergic system

1 reference

12 December 2020

Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors

1 reference

12 December 2020

Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury

1 reference

12 December 2020

In vivo analgesic and anti-inflammatory activities of ursolic acid and oleanoic acid from Miconia albicans (Melastomataceae)

1 reference

12 December 2020

The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress

1 reference

12 December 2020

Chemical composition of the Prunus laurocerasus leaf surface. Dynamic changes of the epicuticular wax film during leaf development

1 reference

12 December 2020

Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types

1 reference

12 December 2020

A phase I pharmacokinetic study of ursolic acid nanoliposomes in healthy volunteers and patients with advanced solid tumors

1 reference

12 December 2020

Cholinesterase inhibitors for Alzheimer's disease

1 reference

12 December 2020

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

12 December 2020

A simple GC-MS method for the screening of betulinic, corosolic, maslinic, oleanolic and ursolic acid contents in commercial botanicals used as food supplement ingredients

1 reference

12 December 2020

Triterpenoid content of berries and leaves of bilberry Vaccinium myrtillus from Finland and Poland

1 reference

12 December 2020

Development of a liquid chromatography–mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution study

1 reference

12 December 2020

Isolation of oleanolic acid and ursolic acid from Thymus vulgaris, L

1 reference

12 December 2020

Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease

1 reference

12 December 2020

Separation and determination of closely related triterpenic acids by high performance thin-layer chromatography after iodine derivatization

1 reference

12 December 2020

A phase I trial to evaluate the multiple-dose safety and antitumor activity of ursolic acid liposomes in subjects with advanced solid tumors

1 reference

12 December 2020

Serotonergic and noradrenergic systems are implicated in the antidepressant-like effect of ursolic acid in mice

1 reference

12 December 2020

Ursolic acid plays a role in Nepeta sibthorpii Bentham CNS depressing effects

1 reference

12 December 2020

Quantitation of ursolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its pharmacokinetic study

1 reference

12 December 2020

The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine

1 reference

12 December 2020

Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis

1 reference

12 December 2020

Antiapoptotic and antioxidant effects of rosmarinic acid in astrocytes.

1 reference

12 December 2020

In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic Acid

1 reference

12 December 2020

Oxidative stress in neurodegenerative diseases

1 reference

12 December 2020

10.1007/S40263-017-0474-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29098660 AND SRC:MED&resulttype=core&format=json

8 April 2020

1 reference